Skip to main content
. Author manuscript; available in PMC: 2008 Jul 8.
Published in final edited form as: Int J Obes (Lond). 2005 Aug;29(8):881–893. doi: 10.1038/sj.ijo.0802959

Table 4.

Primary and secondary outcomes

Variable N ±s.e.m. 95% CI Q P I2
Primary outcomes (mg/dl)
 TC 17 −3.4±1.7 −6.7 to −0.2* 22.8 0.12 29.7
 HDL 15 1.6±0.8 −0.02 to 3.2 46.4 <0.001** 69.8
 LDL 14 −0.5±1.3 −3.0 to 2.0 12.9 0.46 0.0
 TG 14 −16.1±7.3 −30.2 to −2.1* 58.7 <0.001** 77.9
Secondary outcomes
 Body weight (kg) 14 −1.6±0.4 −2.3 to −0.9* 25.0 0.02** 48.1
 BMI (kg/m2) 5 −1.1±0.3 −1.8 to −0.5* 6.1 0.19 34.2
 Body fat (%) 5 −0.1±0.3 −0.8 to 0.6 4.2 0.38 4.2
VO2max (ml/kg−1/min−1) 10 3.5±0.6 2.3 to 4.7* 55.2 <0.001** 83.7

N, number of groups reporting data in which a treatment effect could be calculated; ±s.e.m., mean±standard error of the mean; CI, confidence interval; Q, heterogeneity value; P, significance value for Q; I2, percentage (%) of inconsistency for study results, calculated from Q statistic; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglycerides; BMI, body mass index; VO2max, maximum oxygen consumption.

*

Significantly different from zero (0);

**

statistically significant at P<0.05.